Results 101 to 110 of about 7,610 (207)
Medicine and surgery for intermediate uveitis. [PDF]
Gandhi JS.
europepmc +1 more source
• A 2.8 mm corneal paracentesis positioned opposite to the tumour location enabled fine iris scissors insertion for precise excision of tumour‐bearing iris tissue under miotic guidance with pilocarpine 2%. • A fornix‐based conjunctival peritomy 5 mm from the limbus and stepped scleral flap approach allowed circumferential deep scleral incision with 2–3
Jae‐Ik Kang +2 more
wiley +1 more source
Current approach in diagnosis and management of anterior uveitis
Uveitis is composed of a diverse group of disease entities, which in total has been estimated to cause approximately 10% of blindness. Uveitis is broadly classified into anterior, intermediate, posterior and panuveitis based on the anatomical ...
Agrawal Rupesh +3 more
doaj
Commentary: Macular vessel densities in non-invasive optical coherence tomography angiography: Challenges in intermediate uveitis. [PDF]
Das D +3 more
europepmc +1 more source
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos +4 more
wiley +1 more source
Pattern of uveitis in a referral uveitis clinic in India
The pattern of uveitis changes over time with the emergence or identification of new uveitic entities. The aim of this prospective study was to obtain a correct incidence pattern and aetiology of uveitis cases seen in a uveitis clinic. We studied all new
Das Debashis +2 more
doaj
Purpose: To identify retinal morphological changes in a model of non-infectious anterior and intermediate uveitis and to assess the efficacy of experimental neuroprotective citicoline therapy in the treatment of the disease.
I. S. Horianova +3 more
doaj +1 more source
Risk of Cataract in Intermediate Uveitis. [PDF]
Minkus CL +18 more
europepmc +1 more source
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey +2 more
wiley +1 more source
Approach to Intermediate Uveitis
Kirti Jaisingh +5 more
doaj +1 more source

